Cart
sales@molnova.com
Dechloro Rivaroxaban
CAS No. 1415566-28-7
Dechloro Rivaroxaban( —— )
Catalog No. M37156 CAS No. 1415566-28-7
Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 35 | In Stock |
|
| 5MG | 32 | In Stock |
|
| 10MG | 54 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 161 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 408 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDechloro Rivaroxaban
-
NoteResearch use only, not for human use.
-
Brief DescriptionDechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.
-
DescriptionDechloro Rivaroxaban is a highly selective, orally active inhibitor of Factor Xa. Dechloro Rivaroxaban inhibits human free FXa with a Ki of 0.4 nM. Dechloro Rivaroxaban inhibits prothrombinase activity and fibrin-associated FXa activity with IC50s of 2.1 nM and 92 nM, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFactor Xa
-
RecptorFactor Xa
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415566-28-7
-
Formula Weight401.44
-
Molecular FormulaC19H19N3O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (124.55 mM; Ultrasonic )
-
SMILESO=C(NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O)c1cccs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lang D, et al. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans. Drug Metab Dispos. 2009 May;37(5):1046-55.?
molnova catalog
related products
-
Otamixaban
A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM.
-
Garadacimab
Garadacimab (CSL312) is a potent whole-human IgG4 monoclonal antibody targeting activation factor XII (FXIIa). Garadacimab can be used to study hereditary angioedema.
-
Asundexian
Asundexian (BAY-2433334) is a potent and orally active inhibitor of the coagulation factor FXIa that directly and reversibly binds to the active site of FXIa, thereby inhibiting its activity.Asundexian has an IC50 of 1 nM for human FXIa in buffer.
